ArticleNeurology and therapy2026

Early Cenobamate as a Third-Line Option in Drug-Resistant Focal Epilepsy: A Paradigm Shift?

Fedele Dono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.